Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
INCIDENCE RATES Cancer in Canada (2007) MALES Prostate 27% Lung 15% Colorectal 14% Bladder 6% 82,700 Total 82,700 FEMALES Breast 29% Lung 14% Colorectal 12% Uterus 5% 77,200 Total 77,200 Canadian Cancer Death Rates 2007 38,400 34,300 MALES Lung Colorectal Prostate 29% 12% 11% Total 38,400 FEMALES Lung Breast Colorectal 26% 15.5% 12% Total 34,300 CANCER: FIVE YEAR CANCER SURVIVAL RATES PROSTATE TESTES MELANOMA UTERUS BREAST BLADDER CERVIX COLON/RECTUM ORAL OVARY LEUKEMIA BRAIN STOMACH ESOPHAGUS LUNG PANCREAS US 97% 91% 89% 84% 86% 82% 71% 62% 51%* 53% 46% 22% * 15% 4% BC(06) Cases in US(06) 91% 237,700 95% 90% 63,000 87% 40,800 86% 210,600 77% 56,000 72% 10,000 60% 147,000 62% 42,000 38% 20,300 46% 35,000 23% 23% 22,000 13% 16% 175,000 6% 28,000 CAN (06) 20,700 840 4,500 3,900 22,300 6,400 1,350 20,000 3,200 2,300 4,100 2,500 2,800 1,500 22,700 3,500 Cancer Death Rates*, for Men, US,1930-2002 100 Rate Per 100,000 Lung 80 60 Stomach Prostate 40 Colon & rectum 20 *Age-adjusted to the 2000 US standard population. Source: US Mortality Public Use Data Tapes 1960-2002, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2005. 2000 1995 1990 1985 1980 1975 1970 1965 1960 Liver 1955 1950 1945 1940 1935 Leukemia 1930 0 Pancreas Cancer Death Rates*, for Women, US,1930-2002 100 Rate Per 100,000 80 60 40 Uterus 20 Stomach Lung Breast Colon & rectum Ovary *Age-adjusted to the 2000 US standard population. Source: US Mortality Public Use Data Tapes 1960-2002, US Mortality Volumes 1930-1959, National Center for Health Statistics, Centers for Disease Control and Prevention, 2005. 2000 1995 1990 1985 1980 1975 1970 1965 1960 1955 1950 1945 1940 1935 Pancreas 1930 0 ANTI-CANCER DRUGS (~16B$ /y - worldwide) Cancer - many types of disease, but always growth of cells out of control More dangerous types: 1) rapidly dividing cells which proliferate 2) those that invade normal cells and destroy them 3) METASTASIS: ability to grow at sites distant from origin; cancer cells transported by blood or lymphatic system most difficult to treat Anti-cancer drugs are (generally) equally toxic to cancerous and normal cells: work because cancerous cells are dividing faster so affected most BUT: linings of gut and mouth hair follicles bone marrow are normally rapidly dividing, hence most anti-cancer drugs affect these too and so: Common Side Effects are mostly the same for all drugs: nausea, ulcers+ sore mouth hair loss depress bone marrow, reduce platelets = infections DNA STRAND CROSS LINKING AGENTS (unable to separate for replication) ALKYLATING AGENTS (nitrogen mustards) ANTINEOPLASTICS 1940's: The WWI mustard gas S(CH2CH2Cl)2 is highly toxic to blood, lymph, bone marrow cells since these are fast dividing: suggested a possible treatment Generally now use a Nitrogen mustard: R-N(CH2CH2Cl)2 O O O P Cyclophosphamide (CYTOXAN) N N H Cl O P N N H O Cl N cross links two guanine bases in different DNA strands N N O + + N N N N N N N DNA DNA Widely used on skin cancer, Hodgkin’s disease (enlarged lymph nodes, spleen) and in COCKTAILS with other drugs Dose: 40-50 mg/kg IV at rate 10-20 mg/kg per day (too toxic to give all at once) Has been used to de-fleece sheep! Bone marrow very sensitive, sometimes removed & put back Note on Dosages: Doses of cancer drugs in general are often expressed in mg/m2 Surface Area S = Mass 0.425 x Height 0.725 x 71.84 (in cm2) kg cm for Dave 118 192 S = 24,676 cm2 or 2.47 m2 PLATIN DRUGS (1969) Guanines displace chlorides O Cl O NH3 Pt Pt Cl NH3 O NH3 NH3 O cis-PLATIN (Platinol) Carboplatin (Paraplatin) Good for testicular (90% cure), ovarian cancers OK for bladder Hard on kidneys and nervous system + vomiting Other antineoplastics in use in Canada: Bisulfan, Thiotepa, Temozolomide, Chlorambucil, Estrumustine, Ifosfamide, Mechlorethamine, Melphalan, Carmustine, Lomustine, Streptozocin (see the CPS for details) ANTIMETABOLITES use compounds of similar structure to RNA/DNA nuscleosides, which get incorporated but are useless H N O NH F O H X 5-FU (5-fluorouracyl) [Adrucil] sugar-phosphate N O cells NH sugar-phosphate N O NH CH3 O O In cells, uracil gets converted to the methyl derivative but the F prevents this from happening and the cell does not recognize F as different from H Useful for breast, rectum, colon, ovary, pancreas, liver 800 mg IV / day for 5 days, repeat in a month SIMILARLY 6-Mercaptopurine gets incorporated instead of adenine SH NH2 N N N NH 6-mercaptopurine N N N NH adenine (Purinethol) 2-5 mg/kg daily for 4 weeks, orally for Leukemia N H2N N N N NH CONH OH N H2N N Folic acid COOH N N NH2 CHCH2CH2COOH N CH3 CONH CHCH2CH2COOH Methotrexate COOH We need to eat FOLIC ACID (vitamin B9), methotrexate binds to an enzyme involved in folic acid metabolism more strongly than folic acid itself: fools cells into stopping synthesis of nucleic acids = cell death Used for leukemia (kids), breasts, ovary, colon POWERFUL TERATOGEN: CANNOT USE IF PREGNANT NOTE: bacteria can make folic acid so we will trick these later with sulfonamide drugs, the precursors to penicillin. ANTI-HORMONES (BREAST CANCER) Breast cancer needs estrogen to encode the proteins for growth Circulating estrone and estradiol related to breast cancer (similarly dihydrotestosterone to prostate cancer) ESTROGENS OH OH HO HO Diethylstilbestrol DES Estradiol O NMe2 N O HO S R Tamoxifen Raloxifene OH NMe2 Tamoxifen (R = H) is metabolized to R = OH and then binds to a site (ERE) that acts as a gene promoter for protein synthesis: acts as an antiestrogen blocking replication (transcription) BUT: in some patients, the AP1 (activating protein) promoter site is activated so transcription and tumor growth can still occur O R Raloxifene (Evista) is better to promote bone growth, no effect on uterine tissue: reduced risk of breast cancer 72% in study of 5000 post-menopausal women at 60 mg dose Letrozole (Femara) inhibits estrogen biosynthesis: 2.5 mg suppresses blood estrogens by ~80% O N CF3 N O2N N O N H NC Letrozole Canada (05): O CN Flutamide Exemestane AE: Tamoxifen AA: cyproterone, flutamide, nilutamide ES: anastrozole, exemestane, letrozole E: diethylstilbestrol (DES) AE = antiestrogen; AA = anti-androgen; ES = blocks estrogen synthesis; E = estrogen ANTIBIOTIC TYPE CANCER DRUGS Actinomycin Type Adriamycin O Z O O N O Z NH2 OH COCH2OH OH Z = small cyclic peptides, e.g. Thr O Val Pro CH3O O OH O Sar Met Val HO NH2 Generally, these antibiotics are too toxic for usual antibiotic use: interfere with peptide (small protein) synthesis Bleomycin: used for testicles, head and neck tumors Adriamycin: broad spectrum anti-cancer (all types) Actinomycin, Cactinomycin, Dactinomycin: wide variety of cancers BUT extremely toxic (heart failure) TAXOL (Bristol-Myers-Squibb trademarked name) Paclitaxel is the actual chemical: occurs in Pacific Yew bark (70-400 ppm) and leaves (20-70 ppm): 3 trees required per patient BACCATIN (from clippings) was used by Rhone-Poulenc to make Taxotere (Docetaxel) – approved by FDA for breats cancer in ‘96 TAXOL and Taxotere promotes tubulin assembly in cells: cannot break down to grow so cells die O O O NH O OH O O O OH HO O NH O OH O O O OH O O OH O O H O O H OH O O O O O O OH Paclitaxel HO Baccatin O H OH O O O O Docetaxel OTHER THERAPIES Designer drugs: ene-diynes The ene-diyne is like a mouse trap: tumor cell DNA triggers the trap, allows cyclization to a benzene DIRADICAL – the diradical rips hydrogen atoms from the tumor cell DNA to form benzene, cleaves the strands and kills the cell eg. Dynemycin (next slide) PHOTODYNAMIC THERAPY Drug needs to concentrate at tumor site Should absorb in red ~630nm (flesh absorbs less here) Should produce a species toxic to the tumor Porphyrins and phthalocyanines are suitable SO3CHOHCH3 Cl CH3CHOH N HN NH N CH2CH2COOH N N Al N SO3N HOOCCH2CH2 SO3- a heme porphryn an Al phthalocyanine Photofrin (porfimer sodium) is a mixture of ~200 porphyrins initially by QLT (Vancouver): approved 1977/8 Inject 2-5 mg/kg, wait 1-2 days irradiate with red laser light ~ 630 nm for 30 mins: 3O 2 in cells excited to 1O2 (singlet oxygen) = destroys tissue Body is photosensitive for ~ 1 month Canada: Bladder, Esophagus (75%+); USA (also early Lung) Improved versions use synthetic benzoporphyrins, shorter sun sensitivity, but useful also for macular degeneration in eye. Radiotherapy X-ray and Gamma Knife therapy: external radiation source focused on tumor – lots of collateral damage (burning, scarring) Magic bullet approach: send the radioactivity to the tumor ligand with an affinity for a particular organ M* + M* = or emitter M* + Beta emitters CO2H HO2C N N N N N N CO2H HO2C N m 99 Tc N CO OC CO DOTA M* = Ln3+ = 153Sm, 166Ho, 169Yb Gamma emitter DNA intercalator Iobenguane (mIBG) 123I gamma imaging 131I beta and gamma therapy Cardiolite: heart gamma imaging Boron Neutron Capture Therapy (BNCT) 10B has a high neutron capture cross-section: neutron absorption results in fission to 7Li, 4He and generation of a gamma ray with sufficient energy to penetrate about one cell diameter Ionization by gamma ray damages DNA and kills cell cancerous cell 7 3 1 10 0n 5 4 2 Li B He [B12H11SH]2BSM